Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease Patients
NCT02506868
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
196
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Kidney Disease
End Stage Renal Failure on Dialysis
Anemia
Interventions
DRUG:
Darbepoetin alfa
Sponsor
Biocad